stockrowFulgent Genetics, Inc. (FLGT) vs MedX Health Corp. (MDXHF)
- Fulgent Genetics, Inc. FLGT 22.46 +20.36%
- MedX Health Corp. MDXHF 0.03 0.00%
Fulgent Genetics, Inc. and MedX Health Corp. are both Diagnostics & Research companies. Fulgent Genetics, Inc. is the larger, with a market value of $513.4M against $103.2M — 5.0× the size. MedX Health Corp. grew revenue faster over the last twelve months: 20.1% against 4.67%. Fulgent Genetics, Inc. has the higher net margin (−27.5% vs −1,087.8%) and the lower return on invested capital (−8.22% vs 0.00%). Across the 17 metrics below, Fulgent Genetics, Inc. leads on 12 and MedX Health Corp. on 5.
Valuation
Profitability
| Metric | FLGT | MDXHF | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 33.82% | (1.89%) | 48.32% |
| Operating margin | (39.20%) | (753.38%) | (5.68%) |
| Net margin | (27.53%) | (1,087.83%) | (4.10%) |
| Free cash flow margin | 4.37% | (655.93%) | 0.00% |
| Return on equity | (8.64%) | 63.71% | 0.00% |
| Return on assets | (7.93%) | (840.71%) | (6.05%) |
| Return on invested capital | (8.22%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack